Oral Mucositis

Ragda Abdalla-Aslan; Hannah Wardill; Sharon Elad

doi:10.1007/978-3-030-86510-8_5

Oral Mucositis

Ragda Abdalla-Aslan
, Hannah Wardill
, Sharon Elad

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

2 Citations (Scopus)

Abstract

Mucositis is a generalized term used to denote either oral or gastrointestinal mucositis as a consequence of cancer therapy. This chapter will describe the epidemiology of mucositis in relation to radiation therapy for head and neck cancers, chemotherapy, and hematopoietic stem cell transplantation. Clinical features, risk factors and pathogenesis of mucositis are covered in depth. In addition, the current consensus on mucositis management and economic consequences are reviewed in this chapter. Although considered to have a different pathogenesis, targeted therapy related oral mucosal adverse effects are often referred in the literature as mucositis or stomatitis. This entity is described in this chapter, too.

Original language	English
Title of host publication	Orofacial Supportive Care in Cancer
Subtitle of host publication	A Contemporary Oral Oncology Perspective
Publisher	Springer International Publishing
Pages	49-97
Number of pages	49
ISBN (Electronic)	9783030865108
ISBN (Print)	9783030865092
DOIs	https://doi.org/10.1007/978-3-030-86510-8_5
Publication status	Published or Issued - 1 Jan 2022
Externally published	Yes

Keywords

Chemotherapy
Gastrointestinal mucositis
HSCT
Oral mucositis
Radiation therapy
Targeted therapy

ASJC Scopus subject areas

General Dentistry
General Medicine

Access to Document

10.1007/978-3-030-86510-8_5

Cite this

@inbook{e358c9b9f7e842b283af55730715c28f,

title = "Oral Mucositis",

abstract = "Mucositis is a generalized term used to denote either oral or gastrointestinal mucositis as a consequence of cancer therapy. This chapter will describe the epidemiology of mucositis in relation to radiation therapy for head and neck cancers, chemotherapy, and hematopoietic stem cell transplantation. Clinical features, risk factors and pathogenesis of mucositis are covered in depth. In addition, the current consensus on mucositis management and economic consequences are reviewed in this chapter. Although considered to have a different pathogenesis, targeted therapy related oral mucosal adverse effects are often referred in the literature as mucositis or stomatitis. This entity is described in this chapter, too.",

keywords = "Chemotherapy, Gastrointestinal mucositis, HSCT, Oral mucositis, Radiation therapy, Targeted therapy",

author = "Ragda Abdalla-Aslan and Hannah Wardill and Sharon Elad",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-86510-8\_5",

language = "English",

isbn = "9783030865092",

pages = "49--97",

booktitle = "Orofacial Supportive Care in Cancer",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Oral Mucositis

AU - Abdalla-Aslan, Ragda

AU - Wardill, Hannah

AU - Elad, Sharon

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Mucositis is a generalized term used to denote either oral or gastrointestinal mucositis as a consequence of cancer therapy. This chapter will describe the epidemiology of mucositis in relation to radiation therapy for head and neck cancers, chemotherapy, and hematopoietic stem cell transplantation. Clinical features, risk factors and pathogenesis of mucositis are covered in depth. In addition, the current consensus on mucositis management and economic consequences are reviewed in this chapter. Although considered to have a different pathogenesis, targeted therapy related oral mucosal adverse effects are often referred in the literature as mucositis or stomatitis. This entity is described in this chapter, too.

AB - Mucositis is a generalized term used to denote either oral or gastrointestinal mucositis as a consequence of cancer therapy. This chapter will describe the epidemiology of mucositis in relation to radiation therapy for head and neck cancers, chemotherapy, and hematopoietic stem cell transplantation. Clinical features, risk factors and pathogenesis of mucositis are covered in depth. In addition, the current consensus on mucositis management and economic consequences are reviewed in this chapter. Although considered to have a different pathogenesis, targeted therapy related oral mucosal adverse effects are often referred in the literature as mucositis or stomatitis. This entity is described in this chapter, too.

KW - Chemotherapy

KW - Gastrointestinal mucositis

KW - HSCT

KW - Oral mucositis

KW - Radiation therapy

KW - Targeted therapy

UR - https://www.scopus.com/pages/publications/85152830942

U2 - 10.1007/978-3-030-86510-8_5

DO - 10.1007/978-3-030-86510-8_5

M3 - Chapter

AN - SCOPUS:85152830942

SN - 9783030865092

SP - 49

EP - 97

BT - Orofacial Supportive Care in Cancer

PB - Springer International Publishing

ER -

Oral Mucositis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this